Global Infectious Disease Diagnostic Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Infectious Disease Diagnostic Revenue
• 1.4 Market by Type
  • 1.4.1 Global Infectious Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Instruments
  • 1.4.3 Consumables
  • 1.4.4 Software and Services
• 1.5 Market by Application
  • 1.5.1 Global Infectious Disease Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Hepatitis B virus (HBV)
  • 1.5.3 Hepatitis C virus (HCV)
  • 1.5.4 Acquired Immunodeficiency Syndrome (AIDS)
  • 1.5.5 Tuberculosis (TB)
  • 1.5.6 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • 1.5.7 Human Papillomavirus (HPV) infection
  • 1.5.8 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Infectious Disease Diagnostic Market Perspective (2015-2026)
• 2.2 Global Infectious Disease Diagnostic Growth Trends by Regions
  • 2.2.1 Infectious Disease Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infectious Disease Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infectious Disease Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Infectious Disease Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Infectious Disease Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Infectious Disease Diagnostic Players by Market Size
  • 3.1.1 Global Top Infectious Disease Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global Infectious Disease Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Infectious Disease Diagnostic Market Concentration Ratio
  • 3.2.1 Global Infectious Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostic Revenue in 2019
• 3.3 Infectious Disease Diagnostic Key Players Head office and Area Served
• 3.4 Key Players Infectious Disease Diagnostic Product Solution and Service
• 3.5 Date of Enter into Infectious Disease Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Infectious Disease Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global Infectious Disease Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Infectious Disease Diagnostic Market Size by Application (2015-2020)
• 5.2 Global Infectious Disease Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infectious Disease Diagnostic Market Size (2015-2020)
• 6.2 Infectious Disease Diagnostic Key Players in North America (2019-2020)
• 6.3 North America Infectious Disease Diagnostic Market Size by Type (2015-2020)
• 6.4 North America Infectious Disease Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Infectious Disease Diagnostic Market Size (2015-2020)
• 7.2 Infectious Disease Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe Infectious Disease Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe Infectious Disease Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China Infectious Disease Diagnostic Market Size (2015-2020)
• 8.2 Infectious Disease Diagnostic Key Players in China (2019-2020)
• 8.3 China Infectious Disease Diagnostic Market Size by Type (2015-2020)
• 8.4 China Infectious Disease Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Infectious Disease Diagnostic Market Size (2015-2020)
• 9.2 Infectious Disease Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan Infectious Disease Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan Infectious Disease Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Infectious Disease Diagnostic Market Size (2015-2020)
• 10.2 Infectious Disease Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Infectious Disease Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Infectious Disease Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India Infectious Disease Diagnostic Market Size (2015-2020)
• 11.2 Infectious Disease Diagnostic Key Players in India (2019-2020)
• 11.3 India Infectious Disease Diagnostic Market Size by Type (2015-2020)
• 11.4 India Infectious Disease Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Infectious Disease Diagnostic Market Size (2015-2020)
• 12.2 Infectious Disease Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Infectious Disease Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America Infectious Disease Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche
  • 13.1.1 Roche Company Details
  • 13.1.2 Roche Business Overview
  • 13.1.3 Roche Infectious Disease Diagnostic Introduction
  • 13.1.4 Roche Revenue in Infectious Disease Diagnostic Business (2015-2020))
  • 13.1.5 Roche Recent Development
• 13.2 BioMrieux SA
  • 13.2.1 BioMrieux SA Company Details
  • 13.2.2 BioMrieux SA Business Overview
  • 13.2.3 BioMrieux SA Infectious Disease Diagnostic Introduction
  • 13.2.4 BioMrieux SA Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.2.5 BioMrieux SA Recent Development
• 13.3 Bio-Rad Laboratories
  • 13.3.1 Bio-Rad Laboratories Company Details
  • 13.3.2 Bio-Rad Laboratories Business Overview
  • 13.3.3 Bio-Rad Laboratories Infectious Disease Diagnostic Introduction
  • 13.3.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.3.5 Bio-Rad Laboratories Recent Development
• 13.4 Danaher Corporation
  • 13.4.1 Danaher Corporation Company Details
  • 13.4.2 Danaher Corporation Business Overview
  • 13.4.3 Danaher Corporation Infectious Disease Diagnostic Introduction
  • 13.4.4 Danaher Corporation Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.4.5 Danaher Corporation Recent Development
• 13.5 Becton
  • 13.5.1 Becton Company Details
  • 13.5.2 Becton Business Overview
  • 13.5.3 Becton Infectious Disease Diagnostic Introduction
  • 13.5.4 Becton Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.5.5 Becton Recent Development
• 13.6 Dickinson and Company
  • 13.6.1 Dickinson and Company Company Details
  • 13.6.2 Dickinson and Company Business Overview
  • 13.6.3 Dickinson and Company Infectious Disease Diagnostic Introduction
  • 13.6.4 Dickinson and Company Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.6.5 Dickinson and Company Recent Development
• 13.7 Cepheid
  • 13.7.1 Cepheid Company Details
  • 13.7.2 Cepheid Business Overview
  • 13.7.3 Cepheid Infectious Disease Diagnostic Introduction
  • 13.7.4 Cepheid Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.7.5 Cepheid Recent Development
• 13.8 Abbott
  • 13.8.1 Abbott Company Details
  • 13.8.2 Abbott Business Overview
  • 13.8.3 Abbott Infectious Disease Diagnostic Introduction
  • 13.8.4 Abbott Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.8.5 Abbott Recent Development
• 13.9 DiaSorin.
  • 13.9.1 DiaSorin. Company Details
  • 13.9.2 DiaSorin. Business Overview
  • 13.9.3 DiaSorin. Infectious Disease Diagnostic Introduction
  • 13.9.4 DiaSorin. Revenue in Infectious Disease Diagnostic Business (2015-2020)
  • 13.9.5 DiaSorin. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer